New government consultation on medicine clawbacks will harm investment, says ABPI
The government has launched a consultation into radically changing the Statutory Scheme for branded medicines (known as the Statutory Scheme).
The consultation comes as delicate...
High Court dismissed BGMA’s claim on being excluded from VPAS negotiation
The High Court has dismissed the British Generic Manufacturers Association (BGMA)'s claim on being excluded from ongoing negotiations between the government and industry to...
Susan Rienow takes up role of ABPI President
Susan Rienow, UK Managing Director and Country President of Pfizer is all set to take up her role as President of the Association of...
ABPI appoints Jessamy Baird as its Vice President Elect
The Association of the British Pharmaceutical Industry (ABPI) has appointed Jessamy Baird as Vice-President Elect of the ABPI.
Jessamy is Managing Director/Country Lead, Sanofi UK...
NHS England, ABPI, DHSC begin negotiation for new medicine pricing scheme
The government, NHS England and the Association of the British Pharmaceutical Industry (ABPI) has begun the negotiations for a new voluntary scheme for branded...
BGMA seeks judicial review on being excluded from VPAS negotiation
The British Generic Manufacturers Association (BGMA) has sought a judicial review of the Department of Health and Social Care’s (DHSC) decision to negotiate a new Voluntary...